Followers | 48 |
Posts | 1181 |
Boards Moderated | 0 |
Alias Born | 04/20/2018 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 24, 2018 3:26:12 PM
I am down $17K on my investment in CELZ. However, I'm not worried and in fact picked up 200K more shares today. I'm not telling you this for any reason other than a) you have control to buy or sell your shares as you see fit and b) complaining on this board does absolutely nothing positive. It won't change your outcome.
You need to be proactive and reach out to the company. If you are not willing to do that and only come on this board to whine, that says a lot more about you as an individual than those of us who hold a lot of shares and don't plan to sell. You have the choice and can sell and move on and give your shares to the MM's who are happy to gobble them up at these low prices.
Ask yourself, has anything fundamentally changed with respect to CMTH/CELZ and their business plan in the past day? Have there been positive notifications in the past 24 hours from new doctors (ie Dr. Said) who are communicating on Twitter giving their support. Doctors don't give testimonials on fly by night products as it can affect their credibility. These are high earning, intelligent individuals who have more to lose than gain by attaching themselves to something that may be suspect.
What we do know is CMTH leadership team is smart, proven they can go from take a concept from infancy to commercialization in a highly competitive arena (medical technology) within a narrow timeframe and are working their business plan.
If you need instant gratification, this is not the stock to buy. However, if you've followed the way they have put all the pieces together and are playing their game of chess, it appears they are on the right track to win the game.
But it requires us to have patience. I am not a patient person and don't like seeing one of my holdings drop $17K; however, I'm in this for what is going to happen 6 months from now. Until CMTH/CELZ leadership drops the ball in execution of their objectives, I will give them the benefit of the doubt as they've proven to be shrewd, buttoned-up professionals.
I don't want to offend anyone or come across harshly. I don't post often; however, felt a need to provide some perspective in light of the posts I've read today. If you believe in CMTH/CELZ, that shouldn't change based on what transpires with the stock in a day or week. At some point, this is going to get real traction and take off. When it does, you will be happy you've stayed along for the ride. Enjoy the day!
Recent CELZ News
- Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin • GlobeNewswire Inc. • 06/24/2024 12:30:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/05/2024 08:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM